GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYRY) » Definitions » Cyclically Adjusted Price-to-FCF

Bayer AG (Bayer AG) Cyclically Adjusted Price-to-FCF : 4.89 (As of Apr. 27, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Bayer AG Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Bayer AG's current share price is $7.39. Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $1.51. Bayer AG's Cyclically Adjusted Price-to-FCF for today is 4.89.

The historical rank and industry rank for Bayer AG's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BAYRY' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 4.78   Med: 14.22   Max: 33.49
Current: 4.99

During the past years, Bayer AG's highest Cyclically Adjusted Price-to-FCF was 33.49. The lowest was 4.78. And the median was 14.22.

BAYRY's Cyclically Adjusted Price-to-FCF is ranked better than
96.31% of 325 companies
in the Drug Manufacturers industry
Industry Median: 32.81 vs BAYRY: 4.99

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bayer AG's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $1.280. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $1.51 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bayer AG Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Price-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.47 9.52 9.29 8.77 6.13

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.77 11.19 9.92 8.81 6.13

Competitive Comparison of Bayer AG's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted Price-to-FCF falls into.



Bayer AG Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bayer AG's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=7.39/1.51
=4.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bayer AG's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.28/123.6675*123.6675
=1.280

Current CPI (Dec. 2023) = 123.6675.

Bayer AG Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.081 99.543 -0.101
201406 0.439 99.543 0.545
201409 0.495 99.823 0.613
201412 0.482 99.543 0.599
201503 0.125 99.717 0.155
201506 0.458 100.417 0.564
201509 0.569 100.417 0.701
201512 0.316 99.717 0.392
201603 0.323 100.017 0.399
201606 0.473 100.717 0.581
201609 0.813 101.017 0.995
201612 0.547 101.217 0.668
201703 0.131 101.417 0.160
201706 0.583 102.117 0.706
201709 0.725 102.717 0.873
201712 0.451 102.617 0.544
201803 0.108 102.917 0.130
201806 0.568 104.017 0.675
201809 0.414 104.718 0.489
201812 0.534 104.217 0.634
201903 0.197 104.217 0.234
201906 0.329 105.718 0.385
201909 0.435 106.018 0.507
201912 0.616 105.818 0.720
202003 -0.174 105.718 -0.204
202006 0.524 106.618 0.608
202009 0.425 105.818 0.497
202012 -0.044 105.518 -0.052
202103 -0.937 107.518 -1.078
202106 0.461 108.486 0.526
202109 0.647 109.435 0.731
202112 0.548 110.384 0.614
202203 -0.301 113.968 -0.327
202206 0.418 115.760 0.447
202209 0.486 118.818 0.506
202212 0.468 119.345 0.485
202303 -1.094 122.402 -1.105
202306 -0.034 123.140 -0.034
202309 0.514 124.195 0.512
202312 1.280 123.668 1.280

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bayer AG  (OTCPK:BAYRY) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bayer AG Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (Bayer AG) Business Description

Industry
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.